Cargando…

The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review

SIMPLE SUMMARY: Cancer treatments can cause adverse effects such as cancer-related fatigue. Immune checkpoint inhibitors (ICIs) are a relatively new therapy for some cancers and have shown great promise in helping people. Physical activity has been shown to aid many cancer patients to overcome adver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaver, Amy L., Sharma, Swapnil, Nikita, Nikita, Lefler, Daniel S., Basu-Mallick, Atrayee, Johnson, Jennifer M., Butryn, Meghan, Lu-Yao, Grace
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699800/ https://www.ncbi.nlm.nih.gov/pubmed/34944984 http://dx.doi.org/10.3390/cancers13246364

Ejemplares similares

Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocol
por: Shaver, Amy L, et al.
Publicado: (2022)

Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based Study
por: Nikita, Nikita, et al.
Publicado: (2022)

Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
por: Jang, Se Ryeong, et al.
Publicado: (2021)

Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review
por: Shah, Yash B., et al.
Publicado: (2022)

Feasibility of a Text Messaging–Integrated and Chatbot-Interfaced Self-Management Program for Symptom Control in Patients With Gastrointestinal Cancer Undergoing Chemotherapy: Pilot Mixed Methods Study
por: Gomaa, Sameh, et al.
Publicado: (2023)

Fever of Undetermined Origin During Neoadjuvant Chemoradiotherapy of Gastroesophageal Junction Adenocarcinoma Due to Radiation-induced Liver Disease
por: Bashir, Babar, et al.
Publicado: (2019)

A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer
por: Shah, Yash B., et al.
Publicado: (2022)

Checkpoint Inhibitor in a Melanoma Patient With Polyendocrinopathy and Gangrenous Gallbladder With a Mass
por: Fernandes, Nayson L, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review
por: Salehi, Iman, et al.
Publicado: (2022)

Metabolic Pathways and Targets in Chondrosarcoma
por: Micaily, Ida, et al.
Publicado: (2021)

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
por: Khaddour, Karam, et al.
Publicado: (2020)

Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy
por: Lin, Ruihe, et al.
Publicado: (2023)

Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review
por: Chen, Miaoqi, et al.
Publicado: (2021)

Subjective experiences of physical activity and forecasting bias during behavioral weight loss
por: Crane, Nicole T., et al.
Publicado: (2021)

Addressing barriers to physical activity among women: A feasibility study using social networking-enabled technology
por: Arigo, Danielle, et al.
Publicado: (2015)

Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
por: Martens, A., et al.
Publicado: (2023)

Immune checkpoint inhibitor-associated celiac disease
por: Badran, Yousef R, et al.
Publicado: (2020)

Hematologic Complications of Immune Checkpoint Inhibitors
por: Davis, Elizabeth J., et al.
Publicado: (2019)

Understanding the relationship between subclinical depressive symptoms and physical activity in behavioral weight loss treatment
por: McCausland, Hannah C., et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management
por: Seethapathy, Harish, et al.
Publicado: (2021)

Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors
por: Rapoport, Bernardo Leon
Publicado: (2019)

Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
por: Ando, Yosuke, et al.
Publicado: (2019)

Longitudinal Strain and Troponin I Elevation in Patients Undergoing Immune Checkpoint Inhibitor Therapy
por: Tamura, Yudai, et al.
Publicado: (2022)

Metformin as Host-Directed Therapy for TB Treatment: Scoping Review
por: Naicker, Nikita, et al.
Publicado: (2020)

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis
por: Mooradian, Meghan J, et al.
Publicado: (2020)

Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
por: Gusak, Artem, et al.
Publicado: (2021)

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
por: Tan, Meng H., et al.
Publicado: (2019)

Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review
por: Handford, Jasmine, et al.
Publicado: (2022)

Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy
por: Pohl, Julia, et al.
Publicado: (2022)

Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors
por: Wan, Luying, et al.
Publicado: (2022)

Evidence for the effects of viewing visual artworks on stress outcomes: a scoping review
por: Law, Mikaela, et al.
Publicado: (2021)

A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report
por: Meredith, Luke, et al.
Publicado: (2023)

The Scope of Physiotherapy Rehabilitation in Compressive Myelopathy Managed by Spinal Fusion: A Case Report
por: Burile, Ghanishtha, et al.
Publicado: (2023)

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
por: Duke, Taylor C., et al.
Publicado: (2020)

Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)

Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)

Checkpoint Inhibitors and Hepatotoxicity
por: Malnick, Stephen D. H., et al.
Publicado: (2021)

Checkpoint Inhibitors and the Gut
por: Tran, Tuan, et al.
Publicado: (2022)

Patterns and Predictors of Engagement With Digital Self-Monitoring During the Maintenance Phase of a Behavioral Weight Loss Program: Quantitative Study
por: Crane, Nicole, et al.
Publicado: (2023)

Combination immunomodulation for immune-checkpoint-inhibitor-associated myocarditis
por: Johnson, Douglas B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vuk0037h0g8v61c8omh784jt0k